ArticleACS pharmacology & translational science2019

Discovery of the Migraine Prevention Therapeutic Aimovig (Erenumab), the First FDA-Approved Antibody against a G-Protein-Coupled Receptor.

Chadwick Terence King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.